These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10332073)

  • 1. Topical delivery of caffeine from some commercial formulations.
    Dias M; Farinha A; Faustino E; Hadgraft J; Pais J; Toscano C
    Int J Pharm; 1999 May; 182(1):41-7. PubMed ID: 10332073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Skin Penetration Enhancer and Nanoemulsion Formulations Promote the Human Epidermal Permeation of Caffeine and Naproxen.
    Abd E; Namjoshi S; Mohammed YH; Roberts MS; Grice JE
    J Pharm Sci; 2016 Jan; 105(1):212-20. PubMed ID: 26554868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of solid lipid nanoparticles for caffeine topical administration.
    Puglia C; Offerta A; Tirendi GG; Tarico MS; Curreri S; Bonina F; Perrotta RE
    Drug Deliv; 2016; 23(1):36-40. PubMed ID: 24735249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane properties for permeability testing: Skin versus synthetic membranes.
    Haq A; Dorrani M; Goodyear B; Joshi V; Michniak-Kohn B
    Int J Pharm; 2018 Mar; 539(1-2):58-64. PubMed ID: 29366943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine-loaded niosomes: characterization and in vitro release studies.
    Khazaeli P; Pardakhty A; Shoorabi H
    Drug Deliv; 2007 Oct; 14(7):447-52. PubMed ID: 17994362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permeation of naproxen from saturated solutions and commercial formulations through synthetic membranes.
    Farinha A; Toscano C; Campos R; Bica A; Hadgraft J
    Drug Dev Ind Pharm; 2003 Apr; 29(4):489-94. PubMed ID: 12737541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing the importance of oil-membrane interactions on the transmembrane diffusion of physicochemically diverse compounds.
    Najib ON; Martin GP; Kirton SB; Sallam AS; Murnane D
    Int J Pharm; 2016 Jun; 506(1-2):429-37. PubMed ID: 27012979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal and buccal delivery of methylxanthines through human tissue in vitro.
    Thakur RA; Michniak BB; Meidan VM
    Drug Dev Ind Pharm; 2007 May; 33(5):513-21. PubMed ID: 17520442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes.
    Ascenso A; Raposo S; Batista C; Cardoso P; Mendes T; Praça FG; Bentley MV; Simões S
    Int J Nanomedicine; 2015; 10():5837-51. PubMed ID: 26425085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of chemical dermal absorption by 14 natural products: a quantitative structure permeation analysis of components often found in topical preparations.
    Muhammad F; Jaberi-Douraki M; de Sousa DP; Riviere JE
    Cutan Ocul Toxicol; 2017 Sep; 36(3):237-252. PubMed ID: 27825281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release and permeation kinetics of caffeine from bioadhesive transdermal films.
    Nicoli S; Colombo P; Santi P
    AAPS J; 2005 Sep; 7(1):E218-23. PubMed ID: 16146342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants.
    Nanayakkara GR; Bartlett A; Forbes B; Marriott C; Whitfield PJ; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):129-39. PubMed ID: 16019171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of low-frequency ultrasound-enhanced transdermal transport of fentanyl and caffeine across human and hairless rat skin.
    Boucaud A; Machet L; Arbeille B; Machet MC; Sournac M; Mavon A; Patat F; Vaillant L
    Int J Pharm; 2001 Oct; 228(1-2):69-77. PubMed ID: 11576769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of volatile solvents on transport across model membranes and human skin.
    Oliveira G; Hadgraft J; Lane ME
    Int J Pharm; 2012 Oct; 435(1):38-49. PubMed ID: 22634140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing vehicle effects on skin absorption using artificial membrane assays.
    Karadzovska D; Riviere JE
    Eur J Pharm Sci; 2013 Dec; 50(5):569-76. PubMed ID: 23474357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline- versus imidazole-based ionic liquids as functional ingredients in topical delivery systems: cytotoxicity, solubility, and skin permeation studies.
    Santos de Almeida T; Júlio A; Saraiva N; Fernandes AS; Araújo MEM; Baby AR; Rosado C; Mota JP
    Drug Dev Ind Pharm; 2017 Nov; 43(11):1858-1865. PubMed ID: 28665154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New easy handling and sampling device for bioavailability screening of topical formulations.
    Salmon D; Gilbert E; Gioia B; Haftek M; Pivot C; Verrier B; Pirot F
    Eur J Dermatol; 2015 Apr; 25 Suppl 1():23-9. PubMed ID: 26083671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of terpinyl acetate on the percutaneous absorption of caffeine in rats.
    Joo S; Kim E; Kang W
    Exp Dermatol; 2017 May; 26(5):439-441. PubMed ID: 27717084
    [No Abstract]   [Full Text] [Related]  

  • 19. A Comparison of the Penetration and Permeation of Caffeine into and through Human Epidermis after Application in Various Vesicle Formulations.
    Abd E; Roberts MS; Grice JE
    Skin Pharmacol Physiol; 2016; 29(1):24-30. PubMed ID: 26540487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous absorption between frog species: Variability in skin may influence delivery of therapeutics.
    Llewelyn VK; Berger L; Glass BD
    J Vet Pharmacol Ther; 2020 Jan; 43(1):91-95. PubMed ID: 31769075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.